GE HealthCare Technologies Inc. (NASDAQ: GEHC) Stock Competitors & Peer Comparison
See GEHC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GEHC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEHC | $66.63 | +0.38% | 30.1B | 14.61 | $4.56 | +0.21% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $101.29 | +0.22% | 175.3B | 19.44 | $5.21 | +2.45% |
| MDT | $88.64 | +0.15% | 113.5B | 16.03 | $5.53 | +3.24% |
| SYK | $272.36 | +0.97% | 104.5B | 20.35 | $13.39 | +1.28% |
| BSX | $43.92 | -1.70% | 65.3B | 14.17 | $3.10 | N/A |
| EW | $86.29 | +0.65% | 49.7B | 31.96 | $2.70 | N/A |
| DXCM | $86.62 | -0.97% | 32.7B | 33.97 | $2.55 | N/A |
| PHG | $24.96 | +1.67% | 24.4B | 14.26 | $1.75 | +3.97% |
| ZBH | $91.04 | +1.51% | 17.6B | 10.73 | $8.48 | +1.06% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
GEHC vs BSX-PA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, GEHC's ROE is +0.15%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, GEHC is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
GEHC vs ABT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ABT trades at $101.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ABT's P/E ratio is 19.44. In terms of profitability, GEHC's ROE is +0.15%, compared to ABT's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ABT's competition here
Medtronic plc (NYSE: MDT)
GEHC vs MDT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, MDT has a market cap of 113.5B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while MDT trades at $88.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas MDT's P/E ratio is 16.03. In terms of profitability, GEHC's ROE is +0.15%, compared to MDT's ROE of +0.11%. Regarding short-term risk, GEHC is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
GEHC vs SYK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SYK has a market cap of 104.5B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SYK trades at $272.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SYK's P/E ratio is 20.35. In terms of profitability, GEHC's ROE is +0.15%, compared to SYK's ROE of +0.16%. Regarding short-term risk, GEHC is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
GEHC vs BSX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BSX has a market cap of 65.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BSX trades at $43.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BSX's P/E ratio is 14.17. In terms of profitability, GEHC's ROE is +0.15%, compared to BSX's ROE of +0.15%. Regarding short-term risk, GEHC is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
GEHC vs EW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, EW has a market cap of 49.7B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while EW trades at $86.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas EW's P/E ratio is 31.96. In terms of profitability, GEHC's ROE is +0.15%, compared to EW's ROE of +0.10%. Regarding short-term risk, GEHC is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
GEHC vs DXCM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while DXCM trades at $86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas DXCM's P/E ratio is 33.97. In terms of profitability, GEHC's ROE is +0.15%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, GEHC is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check DXCM's competition here
Koninklijke Philips N.V. (NYSE: PHG)
GEHC vs PHG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PHG has a market cap of 24.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PHG trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PHG's P/E ratio is 14.26. In terms of profitability, GEHC's ROE is +0.15%, compared to PHG's ROE of +0.10%. Regarding short-term risk, GEHC is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
GEHC vs ZBH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ZBH trades at $91.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ZBH's P/E ratio is 10.73. In terms of profitability, GEHC's ROE is +0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, GEHC is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
GEHC vs ABMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ABMD's P/E ratio is 65.36. In terms of profitability, GEHC's ROE is +0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, GEHC is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
GEHC vs SWAV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SWAV's P/E ratio is 78.76. In terms of profitability, GEHC's ROE is +0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, GEHC is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
GEHC vs PEN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PEN trades at $318.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PEN's P/E ratio is 83.25. In terms of profitability, GEHC's ROE is +0.15%, compared to PEN's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
GEHC vs SNN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SNN trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SNN's P/E ratio is 18.17. In terms of profitability, GEHC's ROE is +0.15%, compared to SNN's ROE of +0.12%. Regarding short-term risk, GEHC is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
GEHC vs BIO-B Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, GEHC's ROE is +0.15%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, GEHC is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
GEHC vs ALGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ALGN trades at $146.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ALGN's P/E ratio is 13.38. In terms of profitability, GEHC's ROE is +0.15%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, GEHC is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
GEHC vs BIO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BIO has a market cap of 10.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BIO trades at $381.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BIO's P/E ratio is 41.05. In terms of profitability, GEHC's ROE is +0.15%, compared to BIO's ROE of +0.03%. Regarding short-term risk, GEHC is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
GEHC vs GMED Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while GMED trades at $74.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas GMED's P/E ratio is 16.79. In terms of profitability, GEHC's ROE is +0.15%, compared to GMED's ROE of +0.12%. Regarding short-term risk, GEHC is similarly volatile compared to GMED. This indicates similar risk in terms of short-term price fluctuations for GEHC.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
GEHC vs BRKR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BRKR trades at $64.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BRKR's P/E ratio is 32.25. In terms of profitability, GEHC's ROE is +0.15%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, GEHC is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
GEHC vs BRKRP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BRKRP trades at $470.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BRKRP's P/E ratio is 255.66. In terms of profitability, GEHC's ROE is +0.15%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, GEHC is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
GEHC vs PODD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PODD trades at $136.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PODD's P/E ratio is 23.19. In terms of profitability, GEHC's ROE is +0.15%, compared to PODD's ROE of +0.27%. Regarding short-term risk, GEHC is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
GEHC vs MASI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas MASI's P/E ratio is 44.43. In terms of profitability, GEHC's ROE is +0.15%, compared to MASI's ROE of +0.09%. Regarding short-term risk, GEHC is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
GEHC vs GKOS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while GKOS trades at $154.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas GKOS's P/E ratio is -180.02. In terms of profitability, GEHC's ROE is +0.15%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, GEHC is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check GKOS's competition here
Haemonetics Corporation (NYSE: HAE)
GEHC vs HAE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while HAE trades at $105.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas HAE's P/E ratio is 21.02. In terms of profitability, GEHC's ROE is +0.15%, compared to HAE's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
GEHC vs NARI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NARI's P/E ratio is -59.24. In terms of profitability, GEHC's ROE is +0.15%, compared to NARI's ROE of -0.00%. Regarding short-term risk, GEHC is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
GEHC vs ITGR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ITGR's P/E ratio is 19.89. In terms of profitability, GEHC's ROE is +0.15%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, GEHC is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
GEHC vs LIVN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while LIVN trades at $76.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas LIVN's P/E ratio is 18.20. In terms of profitability, GEHC's ROE is +0.15%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, GEHC is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
GEHC vs AXNX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AXNX's P/E ratio is -709.80. In terms of profitability, GEHC's ROE is +0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, GEHC is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
GEHC vs IRTC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while IRTC trades at $110.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas IRTC's P/E ratio is -256.70. In terms of profitability, GEHC's ROE is +0.15%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, GEHC is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
GEHC vs NEOG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NEOG trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NEOG's P/E ratio is 49.14. In terms of profitability, GEHC's ROE is +0.15%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, GEHC is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
GEHC vs TMDX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while TMDX trades at $85.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas TMDX's P/E ratio is 43.29. In terms of profitability, GEHC's ROE is +0.15%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, GEHC is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
GEHC vs BFLY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BFLY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BFLY's P/E ratio is -39.13. In terms of profitability, GEHC's ROE is +0.15%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, GEHC is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
GEHC vs AXGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AXGN trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AXGN's P/E ratio is 114.18. In terms of profitability, GEHC's ROE is +0.15%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, GEHC is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
GEHC vs UFPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while UFPT trades at $295.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas UFPT's P/E ratio is 30.20. In terms of profitability, GEHC's ROE is +0.15%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, GEHC is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
GEHC vs NUVA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NUVA's P/E ratio is 75.00. In terms of profitability, GEHC's ROE is +0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, GEHC is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
GEHC vs INSP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, INSP has a market cap of 2B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while INSP trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas INSP's P/E ratio is 31.06. In terms of profitability, GEHC's ROE is +0.15%, compared to INSP's ROE of +0.18%. Regarding short-term risk, GEHC is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
GEHC vs ESTA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ESTA trades at $65.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ESTA's P/E ratio is -52.36. In terms of profitability, GEHC's ROE is +0.15%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, GEHC is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
GEHC vs NVCR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NVCR trades at $15.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NVCR's P/E ratio is -12.18. In terms of profitability, GEHC's ROE is +0.15%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, GEHC is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
GEHC vs ATEC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ATEC trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ATEC's P/E ratio is -168.67. In terms of profitability, GEHC's ROE is +0.15%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, GEHC is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
GEHC vs CNMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CNMD trades at $45.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CNMD's P/E ratio is 9.97. In terms of profitability, GEHC's ROE is +0.15%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, GEHC is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
GEHC vs HSKA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas HSKA's P/E ratio is -62.49. In terms of profitability, GEHC's ROE is +0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, GEHC is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
GEHC vs IART Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while IART trades at $16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas IART's P/E ratio is 6.83. In terms of profitability, GEHC's ROE is +0.15%, compared to IART's ROE of -0.01%. Regarding short-term risk, GEHC is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
GEHC vs AVNS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AVNS's P/E ratio is 27.77. In terms of profitability, GEHC's ROE is +0.15%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, GEHC is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
GEHC vs SILK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SILK's P/E ratio is -18.96. In terms of profitability, GEHC's ROE is +0.15%, compared to SILK's ROE of -0.35%. Regarding short-term risk, GEHC is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
GEHC vs AORT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AORT trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AORT's P/E ratio is 37.75. In terms of profitability, GEHC's ROE is +0.15%, compared to AORT's ROE of -0.01%. Regarding short-term risk, GEHC is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AORT's competition here
Paragon 28, Inc. (NYSE: FNA)
GEHC vs FNA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas FNA's P/E ratio is -19.83. In terms of profitability, GEHC's ROE is +0.15%, compared to FNA's ROE of -0.35%. Regarding short-term risk, GEHC is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
GEHC vs IRMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while IRMD trades at $85.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas IRMD's P/E ratio is 43.10. In terms of profitability, GEHC's ROE is +0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, GEHC is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
GEHC vs TNDM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while TNDM trades at $15.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas TNDM's P/E ratio is -16.90. In terms of profitability, GEHC's ROE is +0.15%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, GEHC is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
GEHC vs ENOV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ENOV trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ENOV's P/E ratio is 5.29. In terms of profitability, GEHC's ROE is +0.15%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, GEHC is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
GEHC vs LMRI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, LMRI has a market cap of 981M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while LMRI trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas LMRI's P/E ratio is -19.86. In terms of profitability, GEHC's ROE is +0.15%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, GEHC is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
GEHC vs PRCT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PRCT has a market cap of 979M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PRCT trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PRCT's P/E ratio is -8.87. In terms of profitability, GEHC's ROE is +0.15%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, GEHC is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
GEHC vs BBNX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BBNX has a market cap of 967.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BBNX trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BBNX's P/E ratio is -13.04. In terms of profitability, GEHC's ROE is +0.15%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, GEHC is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BBNX's competition here
Bioventus Inc. (NASDAQ: BVS)
GEHC vs BVS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BVS has a market cap of 935.6M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BVS trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BVS's P/E ratio is 18.17. In terms of profitability, GEHC's ROE is +0.15%, compared to BVS's ROE of +0.28%. Regarding short-term risk, GEHC is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
GEHC vs CBLL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CBLL has a market cap of 898.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CBLL trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CBLL's P/E ratio is -13.46. In terms of profitability, GEHC's ROE is +0.15%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, GEHC is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
GEHC vs CSII Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CSII's P/E ratio is -20.83. In terms of profitability, GEHC's ROE is +0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, GEHC is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
GEHC vs SIBN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SIBN has a market cap of 824.5M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SIBN's P/E ratio is -54.68. In terms of profitability, GEHC's ROE is +0.15%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, GEHC is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
GEHC vs INMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, INMD has a market cap of 819.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while INMD trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas INMD's P/E ratio is 9.90. In terms of profitability, GEHC's ROE is +0.15%, compared to INMD's ROE of +0.12%. Regarding short-term risk, GEHC is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
GEHC vs VREX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas VREX's P/E ratio is 19.42. In terms of profitability, GEHC's ROE is +0.15%, compared to VREX's ROE of +0.05%. Regarding short-term risk, GEHC is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
GEHC vs AHCO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AHCO has a market cap of 767.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AHCO trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AHCO's P/E ratio is 11.51. In terms of profitability, GEHC's ROE is +0.15%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, GEHC is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
GEHC vs AVR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, AVR has a market cap of 747.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while AVR trades at $7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas AVR's P/E ratio is -3.96. In terms of profitability, GEHC's ROE is +0.15%, compared to AVR's ROE of -0.78%. Regarding short-term risk, GEHC is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
GEHC vs CTKB Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CTKB has a market cap of 729.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CTKB trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CTKB's P/E ratio is -29.93. In terms of profitability, GEHC's ROE is +0.15%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, GEHC is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
GEHC vs SRDX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SRDX's P/E ratio is -34.66. In terms of profitability, GEHC's ROE is +0.15%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, GEHC is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SRDX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
GEHC vs SSII Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SSII trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SSII's P/E ratio is -49.17. In terms of profitability, GEHC's ROE is +0.15%, compared to SSII's ROE of -0.27%. Regarding short-term risk, GEHC is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SSII's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
GEHC vs APEN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas APEN's P/E ratio is -9.43. In terms of profitability, GEHC's ROE is +0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, GEHC is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
GEHC vs KIDS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, KIDS has a market cap of 579.2M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while KIDS trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas KIDS's P/E ratio is -19.11. In terms of profitability, GEHC's ROE is +0.15%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, GEHC is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
GEHC vs DCTH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, DCTH has a market cap of 538.5M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while DCTH trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas DCTH's P/E ratio is 1560.00. In terms of profitability, GEHC's ROE is +0.15%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, GEHC is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
GEHC vs ZIMV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, GEHC's ROE is +0.15%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, GEHC is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
GEHC vs CERS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CERS has a market cap of 528M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CERS trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CERS's P/E ratio is -87.04. In terms of profitability, GEHC's ROE is +0.15%, compared to CERS's ROE of -0.10%. Regarding short-term risk, GEHC is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
GEHC vs TCMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, TCMD has a market cap of 512.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while TCMD trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas TCMD's P/E ratio is 21.05. In terms of profitability, GEHC's ROE is +0.15%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, GEHC is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TCMD's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
GEHC vs PACB Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PACB has a market cap of 503.2M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PACB trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PACB's P/E ratio is -3.95. In terms of profitability, GEHC's ROE is +0.15%, compared to PACB's ROE of -49.62%. Regarding short-term risk, GEHC is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PACB's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
GEHC vs SGHT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SGHT has a market cap of 485.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SGHT trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SGHT's P/E ratio is -15.95. In terms of profitability, GEHC's ROE is +0.15%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, GEHC is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SGHT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
GEHC vs NPCE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NPCE has a market cap of 479.4M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NPCE trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NPCE's P/E ratio is -24.67. In terms of profitability, GEHC's ROE is +0.15%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, GEHC is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
GEHC vs CLPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CLPT has a market cap of 444.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CLPT trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CLPT's P/E ratio is -12.57. In terms of profitability, GEHC's ROE is +0.15%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, GEHC is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
GEHC vs SENS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SENS has a market cap of 417.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SENS trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SENS's P/E ratio is -4.48. In terms of profitability, GEHC's ROE is +0.15%, compared to SENS's ROE of -1.66%. Regarding short-term risk, GEHC is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
GEHC vs OFIX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, OFIX has a market cap of 381.6M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while OFIX trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas OFIX's P/E ratio is -6.15. In terms of profitability, GEHC's ROE is +0.15%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, GEHC is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
GEHC vs CV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CV has a market cap of 332.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CV trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CV's P/E ratio is -10.56. In terms of profitability, GEHC's ROE is +0.15%, compared to CV's ROE of -1.78%. Regarding short-term risk, GEHC is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
GEHC vs SMLR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas SMLR's P/E ratio is 3.92. In terms of profitability, GEHC's ROE is +0.15%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, GEHC is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SMLR's competition here
Avita Medical Inc. (NASDAQ: RCEL)
GEHC vs RCEL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, RCEL has a market cap of 294.1M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while RCEL trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas RCEL's P/E ratio is -8.22. In terms of profitability, GEHC's ROE is +0.15%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, GEHC is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check RCEL's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
GEHC vs TMCI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, TMCI has a market cap of 291.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while TMCI trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas TMCI's P/E ratio is -4.79. In terms of profitability, GEHC's ROE is +0.15%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, GEHC is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
GEHC vs CATX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while CATX trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas CATX's P/E ratio is -1.89. In terms of profitability, GEHC's ROE is +0.15%, compared to CATX's ROE of -0.42%. Regarding short-term risk, GEHC is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
GEHC vs TLSI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, TLSI has a market cap of 267.2M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while TLSI trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas TLSI's P/E ratio is -2.58. In terms of profitability, GEHC's ROE is +0.15%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, GEHC is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
GEHC vs INFU Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, INFU has a market cap of 257.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while INFU trades at $12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas INFU's P/E ratio is 31.10. In terms of profitability, GEHC's ROE is +0.15%, compared to INFU's ROE of +0.15%. Regarding short-term risk, GEHC is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
GEHC vs MGRM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas MGRM's P/E ratio is -12.00. In terms of profitability, GEHC's ROE is +0.15%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, GEHC is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
GEHC vs ELMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ELMD has a market cap of 231.4M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ELMD trades at $27.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ELMD's P/E ratio is 21.34. In terms of profitability, GEHC's ROE is +0.15%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, GEHC is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
GEHC vs NVRO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas NVRO's P/E ratio is -1.91. In terms of profitability, GEHC's ROE is +0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, GEHC is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
GEHC vs PROF Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, PROF has a market cap of 209.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while PROF trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas PROF's P/E ratio is -5.88. In terms of profitability, GEHC's ROE is +0.15%, compared to PROF's ROE of -0.56%. Regarding short-term risk, GEHC is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
GEHC vs RXST Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, RXST has a market cap of 192.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while RXST trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas RXST's P/E ratio is -4.12. In terms of profitability, GEHC's ROE is +0.15%, compared to RXST's ROE of -0.17%. Regarding short-term risk, GEHC is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
GEHC vs BSGM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas BSGM's P/E ratio is -5.81. In terms of profitability, GEHC's ROE is +0.15%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, GEHC is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
GEHC vs STIM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, STIM has a market cap of 190.7M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while STIM trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas STIM's P/E ratio is -6.23. In terms of profitability, GEHC's ROE is +0.15%, compared to STIM's ROE of -1.51%. Regarding short-term risk, GEHC is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check STIM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
GEHC vs MDGS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas MDGS's P/E ratio is -0.27. In terms of profitability, GEHC's ROE is +0.15%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, GEHC is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
GEHC vs FOCL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, FOCL has a market cap of 176.5M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while FOCL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas FOCL's P/E ratio is -4.55. In terms of profitability, GEHC's ROE is +0.15%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, GEHC is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
GEHC vs QSI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, QSI has a market cap of 165M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while QSI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas QSI's P/E ratio is -1.81. In terms of profitability, GEHC's ROE is +0.15%, compared to QSI's ROE of -0.47%. Regarding short-term risk, GEHC is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check QSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
GEHC vs QIPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas QIPT's P/E ratio is -15.87. In terms of profitability, GEHC's ROE is +0.15%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, GEHC is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
GEHC vs LUCD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, LUCD has a market cap of 157.6M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while LUCD trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas LUCD's P/E ratio is -2.23. In terms of profitability, GEHC's ROE is +0.15%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, GEHC is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check LUCD's competition here
Quanterix Corporation (NASDAQ: QTRX)
GEHC vs QTRX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, QTRX has a market cap of 154M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while QTRX trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas QTRX's P/E ratio is -1.29. In terms of profitability, GEHC's ROE is +0.15%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, GEHC is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
GEHC vs INGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, INGN has a market cap of 145.1M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while INGN trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas INGN's P/E ratio is -5.89. In terms of profitability, GEHC's ROE is +0.15%, compared to INGN's ROE of -0.13%. Regarding short-term risk, GEHC is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
GEHC vs ICAD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ICAD's P/E ratio is -20.37. In terms of profitability, GEHC's ROE is +0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, GEHC is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
GEHC vs ECOR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ECOR has a market cap of 100.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ECOR trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ECOR's P/E ratio is -6.62. In terms of profitability, GEHC's ROE is +0.15%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, GEHC is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
GEHC vs HJLI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas HJLI's P/E ratio is N/A. In terms of profitability, GEHC's ROE is +0.15%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, GEHC is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
GEHC vs ASXC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 30.1B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, GEHC is priced at $66.63 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 14.61, whereas ASXC's P/E ratio is -1.12. In terms of profitability, GEHC's ROE is +0.15%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, GEHC is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ASXC's competition here